Correlation Between Quantitative Analysis of Coronary MRA and FFR
Quantitative Analysis of 3T Whole Heart Coronary Magnetic Resonance Angiogram Improves Detection of Functionally Significant Coronary Artery Disease
1 other identifier
observational
89
1 country
1
Brief Summary
This study aims to evaluate whether quantitative analysis of coronary MR angiogram would improve the detection of functionally-significant coronary artery stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 12, 2017
CompletedFirst Posted
Study publicly available on registry
April 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2018
CompletedApril 18, 2017
April 1, 2017
3.5 years
April 12, 2017
April 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of functionally significant coronary stenosis
fractional flow reserve \< 0.8
within 1 month
Interventions
Quantitative analysis of coronary MR angiogram
Eligibility Criteria
Patients with coronary stenosis on coronary MR angiograms who were planned to undergo invasive coronary angiography.
You may qualify if:
- Age ≥ 18 years
- or more coronary stenoses in the major coronary artery with a vessel diameter ≥ 2mm on coronary MR angiogram
- Patient who were planned to undergo invasive coronary angiography and fractional flow reserve
You may not qualify if:
- clinically unstable patient
- a history of coronary revascularization
- infiltrative cardiomyopathy, hypertropic cardiomyopathy, myocarditis
- contraindication to use of adenosine
- complete occlusion of target lesion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Bundang Hopsital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 12, 2017
First Posted
April 17, 2017
Study Start
July 1, 2014
Primary Completion
December 31, 2017
Study Completion
May 31, 2018
Last Updated
April 18, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share